Table 2 Clinical data
Case | Sex/Age | Site | Size (cm) | Therapy | Rec/Met, m | Follow-up |
|---|---|---|---|---|---|---|
1 | f/42y | toe | 2.0 | E | NA | NA |
2 | f/63y | occipital | 1.0 | WE, RT, ME | cerv LN, 14 | NED, 2y |
3 | f/58y | groin | NA | NA | NA | NA |
4 | f/66y | lung (mf) | NA | NA | NA | NA |
5 | m/69y | oral cavity | 0.8 | WE | - | NED, 2y |
6 | m/42y | groin | 3.6 | NA | NA | NA |
7 | m/10y | nose bridge | 1.1 | NA | NA | NA |
8 | m/14y | LN, groin | 2.0 | WE | NA | NA |
9 | f/70y | heel | 1.1 | NA | NA | NA |
10 | m/61y | skin/finger | 0.5 | WE | - | NED, 2y |
11 | f/71y | neck | 1.1 | E, R1 | - | NED, 7y |
12 | m/51y | thoracic spine | NA | NA | NA | NA |
13 | f/30y | upper arm | 1.9 | NA | NA | NA |
14 | m/70y | lower arm | 2.0 | NA | NA | NA |
15 | f/85y | paravertebral | 5.4 | NA | NA | NA |
16 | f/78y | breast | NA | NA | NA | NA |
17 | f/41y | neck | 2.5 | WE, RT | - | NED, 3m |
18 | f/60y | axilla | 4.5 | E, RT | - | NED, 1y |
19 | m/68y | lung | 1.4 | WE, TKI* | lung, pleura, mediastinum, 13 | AWD, 2y |
20 | m/54y | lung | 2.2 | WE | NA | NA |
21 | m/43y | mediastinum | 7.5 | E | NA | NA |
22 | f/46y | liver (mf) | 4.5 | WE | - | NED, 1y |
23 | f/70y | liver | NA | CT | pleura, 0 | AWD, 1.5y |
24 | m/49y | maxilla | 3.1 | WE, RT,ME | cerv LN, 5 | NED, 1y |
25 | f/26y | humerus | NA | E | - | NED, 5y |
26 | m/10y | paratesticular | 1.4 | E | NA | NA |
27 | f/55y | rib | 4.5 | WE | NA | NA |
28 | f/49y | mandible | 2.5 | WE | cerv LN | NA |
29 | f/37y | neck | 3.0 | E | LN,bone,lung | DOD, 4 m |
30 | f/81y | femur | NA | NA | NA | NA |
31 | m/19y | lung (mf) | NA | NA | NA | NA |
32 | f/41y | groin | 1.8 | WE, RT | Vulva | NED, 1y |
33 | f/77y | pubic skin | 2.5 | WE | - | NED, 3y |
34 | m/59y | lung | 3.0 | WE, ME | pleura, bone, mesentery, 3 | DOD, 1.5y |
35 | f/25y | neck | 7.5 | E | cerv LN, 0 | NA |
36 | f/9y | lung (mf) | NA | CT | pleura | DOD, 0.5y |
37 | f/10y | lung (mf) | 11 | CT, RT | chest wall | DOD, 0.5y |
38 | m/51y | elbow | 2.4 | E | NA | NA |
39 | f/75y | neck | 2.5 | WE | NA | NA |